The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery
Open accessAbstract
Adoptive cell therapy (ACT) with antigen-specific T cells has shown remarkable clinical success; however, approaches to safely and effectively augment T cell function, especially in solid tumors, remain of great interest. Here we describe a strategy to 'backpack' large quantities of supporting protein drugs on T cells by using protein nanogels (NGs) that selectively release these cargos in response to T cell receptor activation. We designed cell surface–conjugated NGs that responded to an increase in T cell surface reduction potential after antigen recognition and limited drug release to sites of antigen encounter, such as the tumor microenvironment. By using NGs that carried an interleukin-15 super-agonist complex, we demonstrated that, relative to systemic administration of free cytokines, NG delivery selectively expanded T cells 16-fold in tumors and allowed at least eightfold higher doses of cytokine to be administered without toxicity. The improved therapeutic window enabled substantially increased tumor clearance by mouse T cell and human chimeric antigen receptor (CAR)-T cell therapy in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Maude, S. L., Frey, N., Shaw, P. A., Aplenc, R., Barrett, D. M., Bunin, N. J., Chew, A., Gonzalez, V. E., Zheng, Z., Lacey, S. F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407222 · Cited by 5,413
Morgan, R. A., Yang, J. C., Kitano, M., Dudley, M. E., Laurencot, C. M., & Rosenberg, S. A. (2010) · Molecular Therapy · doi:10.1038/mt.2010.24 · Cited by 2,533
Adoptive cell transfer as personalized immunotherapy for human cancer
Rosenberg, S. A., & Restifo, N. P. (2015) · Science · doi:10.1126/science.aaa4967 · Cited by 2,506
Overwijk, W. W., Theoret, M. R., Finkelstein, S. E., Surman, D. R., de Jong, L. A., Vyth-Dreese, F. A., Dellemijn, T. A., Antony, P. A., Spiess, P. J., Palmer, D. C., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030590 · Cited by 925
Kloss, C. C., Condomines, M., Cartellieri, M., Bachmann, M., & Sadelain, M. (2013) · Nature Biotechnology · doi:10.1038/nbt.2459 · Cited by 857
Leonard, J. P., Sherman, M. L., Fisher, G. L., Buchanan, L. J., Larsen, G., Atkins, M. B., Sosman, J. A., Dutcher, J. P., Vogelzang, N. J., & Ryan, J. L. (1997) · PubMed · Cited by 820
Therapeutic cell engineering with surface-conjugated synthetic nanoparticles
Stephan, M. T., Moon, J. J., Um, S. H., Bershteyn, A., & Irvine, D. J. (2010) · Nature Medicine · doi:10.1038/nm.2198 · Cited by 750
Self-citationFedorov, V. D., Themeli, M., & Sadelain, M. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006597 · Cited by 735
Conlon, K. C., Lugli, E., Welles, H. C., Rosenberg, S. A., Fojo, A. T., Morris, J. C., Fleisher, T. A., Dubois, S. P., Perera, L. P., Stewart, D. M., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.3329 · Cited by 711
Remote control of therapeutic T cells through a small molecule–gated chimeric receptor
Wu, C.-Y., Roybal, K. T., Puchner, E. M., Onuffer, J., & Lim, W. A. (2015) · Science · doi:10.1126/science.aab4077 · Cited by 687
Pegram, H. J., Lee, J. C., Hayman, E. G., Imperato, G. H., Tedder, T. F., Sadelain, M., & Brentjens, R. J. (2012) · Blood · doi:10.1182/blood-2011-12-400044 · Cited by 678
IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8 + T Cells
Klebanoff, C. A., Finkelstein, S. E., Surman, D. R., Lichtman, M. K., Gattinoni, L., Theoret, M. R., Grewal, N., Spiess, P. J., Antony, P. A., Palmer, D. C., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307298101 · Cited by 577
Chmielewski, M., Kopecky, C., Hombach, A. A., & Abken, H. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0103 · Cited by 562
Johnson, L. A., Scholler, J., Ohkuri, T., Kosaka, A., Patel, P. R., McGettigan, S. E., Nace, A. K., Dentchev, T., Thekkat, P., Loew, A., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa4963 · Cited by 454
Self-citationZhang, L., Morgan, R. A., Beane, J. D., Zheng, Z., Dudley, M. E., Kassim, S. H., Nahvi, A. V., Ngo, L. T., Sherry, R. M., Phan, G. Q., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2085 · Cited by 444
Bioresponsive Mesoporous Silica Nanoparticles for Triggered Drug Release
Singh, N., Karambelkar, A., Gu, L., Lin, K., Miller, J. S., Chen, C. S., Sailor, M. J., & Bhatia, S. N. (2011) · Journal of the American Chemical Society · doi:10.1021/ja206998x · Cited by 363
Injectable, porous, and cell-responsive gelatin cryogels
Koshy, S. T., Ferrante, T. C., Lewin, S. A., & Mooney, D. J. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.044 · Cited by 331
Going viral: chimeric antigen receptor T‐cell therapy for hematological malignancies
Gill, S., & June, C. H. (2015) · Immunological Reviews · doi:10.1111/imr.12243 · Cited by 320
Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells
Huang, B., Abraham, W. D., Zheng, Y., Bustamante López, S. C., Luo, S. S., & Irvine, D. J. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa5447 · Cited by 312
Self-citationInitiation of T cell signaling by CD45 segregation at 'close contacts'
Chang, V. T., Fernandes, R. A., Ganzinger, K. A., Lee, S. F., Siebold, C., McColl, J., Jönsson, P., Palayret, M., Harlos, K., Coles, C. H., et al. (2016) · Nature Immunology · doi:10.1038/ni.3392 · Cited by 290
Tumor-Specific Activation of an EGFR-Targeting Probody Enhances Therapeutic Index
Desnoyers, L. R., Vasiljeva, O., Richardson, J. H., Yang, A., Menendez, E. E. M., Liang, T. W., Wong, C., Bessette, P. H., Kamath, K., Moore, S. J., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006682 · Cited by 281
Chinnasamy, D., Yu, Z., Kerkar, S. P., Zhang, L., Morgan, R. A., Restifo, N. P., & Rosenberg, S. A. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3050 · Cited by 277
Adoptive Immunotherapy for Cancer or Viruses
Maus, M. V., Fraietta, J. A., Levine, B. L., Kalos, M., Zhao, Y., & June, C. H. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120136 · Cited by 264
Self-citationThiol–Disulfide Balance: From the Concept of Oxidative Stress to that of Redox Regulation
Ghezzi, P., Bonetto, V., & Fratelli, M. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.964 · Cited by 241
Rhode, P. R., Egan, J. O., Xu, W., Hong, H., Webb, G. M., Chen, X., Liu, B., Zhu, X., Wen, J., You, L., et al. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0093-t · Cited by 225
Self-citationHan, K.-P., Zhu, X., Liu, B., Jeng, E., Kong, L., Yovandich, J. L., Vyas, V. V., Marcus, W. D., Chavaillaz, P.-A., Romero, C. A., et al. (2011) · Cytokine · doi:10.1016/j.cyto.2011.09.028 · Cited by 223
Self-citationSynapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles
Stephan, M. T., Stephan, S. B., Bak, P., Chen, J., & Irvine, D. J. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.04.029 · Cited by 209
Self-citationA supramolecular basis for CD45 tyrosine phosphatase regulation in sustained T cell activation
Johnson, K. G., Bromley, S. K., Dustin, M. L., & Thomas, M. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.18.10138 · Cited by 200
Novel Human Interleukin-15 Agonists
Zhu, X., Marcus, W. D., Xu, W. V., Lee, H.-I., Han, K., Egan, J. O., Yovandich, J. L., Rhode, P. R., & Wong, H. C. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901244 · Cited by 155
Self-citationJones, L. R., Goun, E. A., Shinde, R., Rothbard, J. B., Contag, C. H., & Wender, P. A. (2006) · Journal of the American Chemical Society · doi:10.1021/ja0586283 · Cited by 155
In vivo targeting of adoptively transferred T-cells with antibody- and cytokine-conjugated liposomes
Zheng, Y., Stephan, M. T., Gai, S. A., Abraham, W. D., Shearer, A., & Irvine, D. J. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.05.037 · Cited by 145
Self-citationLing, D., Xia, H., Park, W., Hackett, M., Song, C., Na, K., Hui, K. M., & Hyeon, T. (2014) · ACS Nano · doi:10.1021/nn502074x · Cited by 138
Au, K. M., Satterlee, A., Min, Y., Tian, X., Kim, Y. S., Caster, J. M., Zhang, L., Zhang, T., Huang, L., & Wang, A. Z. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.12.018 · Cited by 136
IL-15 Superagonist–Mediated Immunotoxicity: Role of NK Cells and IFN-γ
Guo, Y., Luan, L., Rabacal, W., Bohannon, J. K., Fensterheim, B. A., Hernandez, A., & Sherwood, E. R. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500300 · Cited by 103
Surface thiols of human lymphocytes and their changes after in vitro and in vivo activation
Lawrence, D. A., Song, R., & Webert, P. (1996) · Journal of Leukocyte Biology · doi:10.1002/jlb.60.5.611 · Cited by 103
Berridge, M. V., & Tan, A. S. (1998) · PROTOPLASMA · doi:10.1007/bf01279296 · Cited by 99
Scott, E. A., Nichols, M. D., Cordova, L. H., George, B., Jun, Y., & Elbert, D. L. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.08.003 · Cited by 89
Self‐Immolative Linkers Literally Bridge Disulfide Chemistry and the Realm of Thiol‐Free Drugs
Frich, C. K., Autzen, A. A. A., & Zelikin, A. N. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500344 · Cited by 87
Wallace, A. F., Kapoor, V., Sun, J., Mrass, P., Weninger, W., Heitjan, D. F., June, C. H., Kaiser, L. R., Ling, L. E., & Albelda, S. Μ. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0356 · Cited by 87
Lin, X., Zheng, W., Liu, J., Zhang, Y., Qin, H., Wu, H., Xue, B., Lu, Y., & Shen, P. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4617 · Cited by 85
The Spectrin-Ankyrin Skeleton Controls CD45 Surface Display and Interleukin-2 Production
Pradhan, D., & Morrow, J. S. (2002) · Immunity · doi:10.1016/s1074-7613(02)00396-5 · Cited by 72
Wang, L., Hess, A., Chang, T. Z., Wang, Y., Champion, J. A., Compans, R. W., & Wang, B. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.08.005 · Cited by 65
T-Cell Immunotherapy: Looking Forward
Corrigan‐Curay, J., Kiem, H., Baltimore, D., O’Reilly, M., Brentjens, R. J., Cooper, L. J. N., Forman, S. J., Gottschalk, S. M., Greenberg, P. D., Junghans, R. P., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.148 · Cited by 65
Rendering Protein-Based Particles Transiently Insoluble for Therapeutic Applications
Xu, J., Wang, J., Luft, J. C., Tian, S., Owens, G., Pandya, A., Berglund, P., Pohlhaus, P. D., Maynor, B. W., Smith, J., et al. (2012) · Journal of the American Chemical Society · doi:10.1021/ja302363r · Cited by 64
Patel, S. K., Zhang, Y., Pollock, J. A., & Janjic, J. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055802 · Cited by 55
Berridge, M. V., & Tan, A. S. (2000) · Antioxidants and Redox Signaling · doi:10.1089/ars.2000.2.2-277 · Cited by 50
Yu, A., Olosz, F., Choi, C. Y., & Malek, T. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2556 · Cited by 41
Membrane-attached Cytokines Expressed by mRNA Electroporation Act as Potent T-Cell Adjuvants
Weinstein-Marom, H., Pato, A., Levin, N., Susid, K., Itzhaki, O., Besser, M. J., Peretz, T., Margalit, A., Lotem, M., & Gross, G. (2016) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000109 · Cited by 25
Cited by
Engineering strategies to overcome the current roadblocks in CAR T cell therapy
Rafiq, S., Hackett, C. S., & Brentjens, R. J. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0297-y · Cited by 1,472
The evolution of commercial drug delivery technologies
Vargason, A. M., Anselmo, A. C., & Mitragotri, S. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00698-w · Cited by 1,361
Targeting Strategies for Tissue-Specific Drug Delivery
Zhao, Z., Ukidve, A., Kim, J., & Mitragotri, S. (2020) · Cell · doi:10.1016/j.cell.2020.02.001 · Cited by 1,099
Cancer nanomedicine for combination cancer immunotherapy
Nam, J., Son, S., Park, K. S., Zou, W., Shea, L. D., & Moon, J. J. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0108-1 · Cited by 940
Enhancing cancer immunotherapy with nanomedicine
Irvine, D. J., & Dane, E. L. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0269-6 · Cited by 882
Self-citation
Metadata
- Authors
- Tang, L., Zheng, Y., Melo, M. B., Mabardi, L., Castaño, A. P., Xie, Y.-Q., Li, N., Kudchodkar, S. B., Wong, H. C., Jeng, E. K., Maus, M. V., & Irvine, D. J.
- Venue
- Nature Biotechnology
- Published
- 2018-07-09
- Volume
- 36
- Issue
- 8
- Pages
- 707-716
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2836754285
- Cited by
- 660
- References
- 48
- FWCI
- 21.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.